1. Alvarez Sotomayor E, Teicher BA, Schwartz GN, Holden SA, Meno K, Herman TS, Frei E (1992) Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo. Cancer Chemother Pharmacol 30:377–384
2. Frei E III (1992) Pharmacologic strategies for high-dose chemotherapy. In: Armitage JO, Antman KH (eds) High-dose cancer therapy: pharmacology, hematopoietins, stem cells. Williams & Wilkins, Baltimore, pp 3–13
3. Frei E III, Antman KH (1993) Combination chemotherapy, dose, and schedule: section XV, principles of chemotherapy. In: Holland JF, Frei E III, Bast RC Jr, Kufe DW, Morton DL, Weichselbaum RR (eds) Cancer medicine Lea & Febiger, Philadelphia, pp 631–639
4. Frei E III, Teicher BA, Holden SA, Cathcart KNS, Wang Y (1988) Preclinical studies and clinical correlation of the effect of alkylating dose. Cancer Res 48:6417–6423
5. Frei E III, Holden SA, Gonin R, Waxman DJ, Teicher BA (1994) Antitumor alkylating agents: in vitro cross-resistance and collateral sensitivity studies. Cancer Chemother Pharmacol (in press)